Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Hydroxychloroquine[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[27] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
2Hydroxychloroquine (Z0188)[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[1] 49
3Hydroxychloroquine + low-dose prednisone[2] Hydroxychloroquine,
Prednisone		[2] D00473 ,
D08050 (Name: Hydroxychloroquine)		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
4Hydroxychloroquine + Prednisone[2] Hydroxychloroquine,
Prednisone		[2] D00473 ,
D08050 (Name: Hydroxychloroquine)		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
5Hydroxychloroquine 400mg/d[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[1] 53
6Hydroxychloroquine and Indapamide[2] Hydroxychloroquine,
Indapamide		[3] D00345 ,
D06401 ,
D08050 (Name: Hydroxychloroquine)		[1] SLC12A3 💬-[1] 13
7Hydroxychloroquine higher dose[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[1] 90
8Hydroxychloroquine lower dose[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[1] 90
9Hydroxychloroquine or Chloroquine[2] Chloroquine,
Hydroxychloroquine		[4] D02125 ,
D02366 ,
D03469 ,
D08050 (Name: Hydroxychloroquine)		--[1] 49
10Hydroxychloroquine reduced[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[1] 49
11HYDROXYCHLOROQUINE SULFATE[2] Hydroxychloroquine,
Sulfate ion		[1] D08050 (Name: Hydroxychloroquine)--[3] 46, 53, 66
12Hydroxychloroquine Sulfate 100 milligram (mg) Tab[2] Hydroxychloroquine,
Sulfate ion		[1] D08050 (Name: Hydroxychloroquine)--[1] 218
13HYDROXYCHLOROQUINE SULPHATE[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[1] 96
14Leflunomide-Sulfasalazine-Hydroxychloroquine[3] Hydroxychloroquine,
Leflunomide,
Sulfasalazine		[3] D00448 ,
D00749 ,
D08050 (Name: Hydroxychloroquine)		[1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 46
15Methotrexate + salazopyrine + hydroxychloroquine administration[2] Hydroxychloroquine,
Methotrexate		[3] D00142 ,
D02115 ,
D08050 (Name: Hydroxychloroquine)		[2] DHFR,
DHFR2 💬		[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬[1] 46
16Methotrexate-Sulfasalazine-Hydroxychloroquine[3] Hydroxychloroquine,
Methotrexate,
Sulfasalazine		[4] D00142 ,
D00448 ,
D02115 ,
D08050 (Name: Hydroxychloroquine)		[2] DHFR,
DHFR2 💬		[5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬[1] 46
17Other: Hydroxychloroquine/Chloroquine[2] Chloroquine,
Hydroxychloroquine		[4] D02125 ,
D02366 ,
D03469 ,
D08050 (Name: Hydroxychloroquine)		--[1] 46
18Plaquenil - Hydroxychloroquine 200mg Film coated tablets[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[3] 43, 44, 45
19Sirolimus and Hydroxychloroquine 200 mg[2] Hydroxychloroquine,
Sirolimus		[2] D00753 ,
D08050 (Name: Hydroxychloroquine)		[1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 89
20Sirolimus and Hydroxychloroquine 400 mg[2] Hydroxychloroquine,
Sirolimus		[2] D00753 ,
D08050 (Name: Hydroxychloroquine)		[1] MTOR 💬[51] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬[1] 89
21Sulfasalazine + Hydroxychloroquine[2] Hydroxychloroquine,
Sulfasalazine		[2] D00448 ,
D08050 (Name: Hydroxychloroquine)		--[1] 46
22Sulfate d'hydroxychloroquine[2] Hydroxychloroquine,
Sulfate ion		[1] D08050 (Name: Hydroxychloroquine)--[1] 53
23Sulphasalazine + Hydroxychloroquine OR Prednisolone[2] Hydroxychloroquine,
Prednisolone		[9] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301 ,
D08050 (Name: Hydroxychloroquine)		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
24Versus hydroxychloroquine[1] Hydroxychloroquine[1] D08050 (Name: Hydroxychloroquine)--[1] 49